SCHEMBL30741065

SCHEMBL30741065

CCOC(=O)c1cc(-c2ccc(C3CC3)cc2)[nH]c1-c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GCGR P47871 2/20 0.56
PDE3B Q13370 2/20 0.52
PDE3A Q14432 2/20 0.52
MDM2 Q00987 3/20 0.45
TUBB4A P04350 1/20 0.44
TUBB P07437 1/20 0.44
TUBA3C P0DPH7 1/20 0.44
TUBA1B P68363 1/20 0.44
TUBA4A P68366 1/20 0.44
TUBB4B P68371 1/20 0.44
TUBB3 Q13509 1/20 0.44
TUBB2A Q13885 1/20 0.44
TUBB8 Q3ZCM7 1/20 0.44
TUBA3E Q6PEY2 1/20 0.44
TUBA1A Q71U36 1/20 0.44
TUBA1C Q9BQE3 1/20 0.44
TUBB6 Q9BUF5 1/20 0.44
TUBB2B Q9BVA1 1/20 0.44
TUBB1 Q9H4B7 1/20 0.44
MAPT P10636 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30741015 0.82 GCGR (0.60) GCGRPDE3BPDE3AMDM2TUBB4A
SCHEMBL30741082 0.81 GCGR (0.58) GCGRPDE3BPDE3AMDM2TUBB4A
SCHEMBL30741084 0.81 GCGR (0.58) GCGRPDE3BPDE3AMDM2TUBB4A
SCHEMBL30740926 0.81 GCGR (0.58) GCGRPDE3BPDE3AMDM2TUBB4A
SCHEMBL4183471 0.81 GCGR (0.78) GCGRPDE3BPDE3ACDC7CCNA2
SCHEMBL30741085 0.81 GCGR (0.57) GCGRPDE3BPDE3AMDM2TUBB4A
SCHEMBL29159037 0.80 GCGR (0.57) GCGRPDE3BPDE3AMDM2TUBB4A
SCHEMBL30741033 0.80 GCGR (0.56) GCGRPDE3BPDE3AMAPTMEN1
SCHEMBL30741005 0.79 GCGR (0.58) GCGRPDE3BPDE3AMDM2TUBB4A
SCHEMBL30741073 0.79 PDE3B (0.56) GCGRPDE3BPDE3AMDM2TUBB4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117396465-A Novel oxazole derivative for preventing or treating allergic diseases and pharmaceutical composition containing the same 阿斯克里斯有限公司 2024-01-12 CN disclosed